Other Information.
+Added: During the three months ended March 31, 2025, none of our directors or officers (as defined in Rule 16a - 1 (f) of the Securities and Exchange Act of 1934 ) adopted or terminated any "Rule 10b5 - 1 trading arrangement" or "non-rule 10b5 - 1 trading arrangement" as each term is defined in Item 408 (a) of Regulation S-K, except as follows:
+Added: - On March 27, 2025 , Cynthia French , our Chief Financial Officer , adopted a new written trading plan intended to satisfy the affirmative defense conditions of Rule 10b5 - 1 (c) under the Exchange Act for the potential exercise and sale of up to (i) 500,000 nonqualified stock options with an exercise price of $0.171 per share and an expiration date of August 7, 2026 and (ii) 150,000 nonqualified stock options with an exercise price of $0.33 per share and an expiration date of February 9, 2027.
+Added: The first trade date, if any, will not occur until July 1, 2025 at the earliest, and the plan's maximum duration is until March 27, 2026, unless otherwise terminated.
Description of Exhibit
15 unchanged sentences
ParkerVision, Inc.
−Removed: November 13, 2024
/s/Jeffrey L.
1 unchanged sentence
(Principal Executive Officer)
−Removed: November 13, 2024
/s/Cynthia L.
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.